Celltrion expands Vietnam portfolio with two oncology biosimilars Korea Biomedical Review 03:34 Mon, 15 Jun
Labor disputes emerge as new risk for Samsung Biologics, Celltrion The Korea Herald 03:24 Thu, 11 Jun
Celltrion picks AI, organoid startups for latest open innovation program Korea Biomedical Review 07:09 Wed, 10 Jun
Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)... JD Supra 16:51 Mon, 08 Jun
Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - June 2026 JD Supra 19:15 Fri, 05 Jun
Celltrion workers establish company's first labor union, demand compensation transparency Korea JoongAng Daily 11:05 Mon, 01 Jun
Celltrion files for approval of Cosentyx biosimilar, CT-P55, in Canada Korea Biomedical Review 07:57 Mon, 01 Jun
Celltrion begins final preclinical studies for obesity drug CT-G32 Korea Biomedical Review 06:34 Fri, 29 May